BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30523223)

  • 41. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma.
    Yan L; Dong X; Gao J; Liu F; Zhou L; Sun Y; Zhao X
    Cancer Med; 2018 May; 7(5):1802-1813. PubMed ID: 29577639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic and prognostic value of serum miRNA-1290 in human esophageal squamous cell carcinoma.
    Sun H; Wang L; Zhao Q; Dai J
    Cancer Biomark; 2019; 25(4):381-387. PubMed ID: 31306104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.
    Zheng X; Xing S; Liu XM; Liu W; Liu D; Chi PD; Chen H; Dai SQ; Zhong Q; Zeng MS; Liu WL
    BMC Cancer; 2014 Jul; 14():490. PubMed ID: 25001061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
    Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
    World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.
    Tanaka Y; Kamohara H; Kinoshita K; Kurashige J; Ishimoto T; Iwatsuki M; Watanabe M; Baba H
    Cancer; 2013 Mar; 119(6):1159-67. PubMed ID: 23224754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
    Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
    Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a panel of autoantibody against NSG1 with CEA, CYFRA21-1, and SCC-Ag for the diagnosis of esophageal squamous cell carcinoma.
    Zheng Q; Zhang L; Tu M; Yin X; Cai L; Zhang S; Yu L; Pan X; Huang Y
    Clin Chim Acta; 2021 Sep; 520():126-132. PubMed ID: 34119530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous disruption of circulating miR-21 and cytotoxic T lymphocytes (CTLs): Prospective diagnostic and prognostic markers for esophageal squamous cell carcinoma (ESCC).
    Samiei H; Ajam F; Gharavi A; Abdolmaleki S; Kokhaei P; Mohammadi S; Memarian A
    J Clin Lab Anal; 2022 Jan; 36(1):e24125. PubMed ID: 34799871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma.
    Hirajima S; Komatsu S; Ichikawa D; Takeshita H; Konishi H; Shiozaki A; Morimura R; Tsujiura M; Nagata H; Kawaguchi T; Arita T; Kubota T; Fujiwara H; Okamoto K; Otsuji E
    Br J Cancer; 2013 May; 108(9):1822-9. PubMed ID: 23579215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study.
    Miyoshi J; Zhu Z; Luo A; Toden S; Zhou X; Izumi D; Kanda M; Takayama T; Parker IM; Wang M; Gao F; Zaidi AH; Baba H; Kodera Y; Cui Y; Wang X; Liu Z; Goel A
    Mol Cancer; 2022 Feb; 21(1):44. PubMed ID: 35148754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma.
    Hoshino I; Ishige F; Iwatate Y; Gunji H; Kuwayama N; Nabeya Y; Yokota H; Takeshita N; Iida K; Nagase H; Matsubara H
    PLoS One; 2021; 16(3):e0248016. PubMed ID: 33690683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA Expression in Plasma of Esophageal Squamous Cell Carcinoma Patients.
    Kahng DH; Kim GH; Park SJ; Kim S; Lee MW; Lee BE; I H
    J Korean Med Sci; 2022 Jun; 37(24):e197. PubMed ID: 35726148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
    Zhang T; Wang Q; Zhao D; Cui Y; Cao B; Guo L; Lu SH
    Clin Sci (Lond); 2011 Nov; 121(10):437-47. PubMed ID: 21658006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia.
    Shen Y; Ding Y; Ma Q; Zhao L; Guo X; Shao Y; Niu C; He Y; Zhang F; Zheng D; Wei W; Liu F
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1212-1220. PubMed ID: 30988139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers.
    Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Clin Chem Lab Med; 2010 Oct; 48(10):1467-73. PubMed ID: 20604722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
    Huang SK; Wang J; Li Y; Lin H; Li DD; Cui CJ; Wang GJ; Li XX; Yang L; Zhao M; Huang CZ
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):441-445. PubMed ID: 29936770
    [No Abstract]   [Full Text] [Related]  

  • 59. [Development and validation of predictive models for esophageal squamous cell carcinoma and its precancerous lesions using terminal motif analysis in circulating cell-free DNA].
    Liu SY; Li ZQ; Dou LZ; Zhang YM; Liu Y; Liu YM; Ke Y; Liu XD; Wu HR; Chu JT; He S; Wang GQ
    Zhonghua Zhong Liu Za Zhi; 2024 Jun; 46(6):549-565. PubMed ID: 38880735
    [No Abstract]   [Full Text] [Related]  

  • 60. [Mechanisms of the suppression of proliferation and invasion ability mediated by microRNA-147b in esophageal squamous cell carcinoma].
    Tang Y; Li Z; Shi ZX
    Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(26):2092-2098. PubMed ID: 30032507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.